Sulfateq BV | Empowering health
  • Home
  • About us
  • Programs & Pipeline
  • Scientific data
  • Partnering
    • Investors
  • Newsroom
  • Contact us
Select Page

The Sulfateq compound SUL-121 is proven to potentially contribute to the treatment of COPD

by Raymond Tel | Jun 8, 2015 | COPD, Events, Hibernation, News, Poster release, Treatment

We are proud to announce that one of our SUL-compounds, SUL-121, is proven to have both an anti-inflammatory and bronchodilating effect in vitro and in vivo. In the study, performed by the University of Groningen, the researchers explored the anti-inflammatory and...
  • RSS
Sulfateq BV - Copyright 2021